Search research articles
Contact Us
Filters
Showing results (61-70 of 154) with videos related to
Page
of 16
Sort By:
Journal of Neuro-Oncology
|
September 25, 2025
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups
Paolo Tini, Flavio Donnini, Francesco Marampon, et al.
Oncology Letters
|
March 22, 2016
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis
Luigi Zugaro, Mario DI Staso, Giovanni Luca Gravina, et al.
BJR Case Reports
|
October 10, 2022
Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review
Francesco Marampon, Alain J Gelibter, Pier Rodolfo Cicco, et al.
BMC Cancer
|
December 2, 2015
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models
Giovanni Luca Gravina, Andrea Mancini, Patrizia Sanita, et al.
International Journal of Oncology
|
December 3, 2011
Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, Ilaria Giusti, et al.
International Journal of Oncology
|
January 3, 2025
[Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, Ilaria Giusti, et al.
International Journal of Molecular Sciences
|
March 14, 2026
Integrative Meta-Analysis Identifies Epithelial-Mesenchymal Transition Gene Signatures as Key Determinants of Ovarian Cancer Progression and Treatment Outcome
Matteo Cassandri, Paola Pontecorvi, Fabrizio Cece, et al.
Oncology Reports
|
December 21, 2012
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
Giovanni Luca Gravina, Guido Ranieri, Paola Muzi, et al.
Journal of Hematology & Oncology
|
January 7, 2017
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Giovanni Luca Gravina, Andrea Mancini, Francesco Marampon, et al.
International Journal of Molecular Sciences
|
September 9, 2022
The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
Tania Colasanti, Katia Stefanantoni, Cristina Fantini, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 154) with videos related to
Sort By:
Page
of 16
Journal of Neuro-Oncology
|
September 25, 2025
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas-prognostic significance in different biological sub-groups
Paolo Tini, Flavio Donnini, Francesco Marampon, et al.
Oncology Letters
|
March 22, 2016
Treatment of osteolytic solitary painful osseous metastases with radiofrequency ablation or cryoablation: A retrospective study by propensity analysis
Luigi Zugaro, Mario DI Staso, Giovanni Luca Gravina, et al.
BJR Case Reports
|
October 10, 2022
Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review
Francesco Marampon, Alain J Gelibter, Pier Rodolfo Cicco, et al.
BMC Cancer
|
December 2, 2015
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models
Giovanni Luca Gravina, Andrea Mancini, Patrizia Sanita, et al.
International Journal of Oncology
|
December 3, 2011
Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, Ilaria Giusti, et al.
International Journal of Oncology
|
January 3, 2025
[Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, Ilaria Giusti, et al.
International Journal of Molecular Sciences
|
March 14, 2026
Integrative Meta-Analysis Identifies Epithelial-Mesenchymal Transition Gene Signatures as Key Determinants of Ovarian Cancer Progression and Treatment Outcome
Matteo Cassandri, Paola Pontecorvi, Fabrizio Cece, et al.
Oncology Reports
|
December 21, 2012
Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
Giovanni Luca Gravina, Guido Ranieri, Paola Muzi, et al.
Journal of Hematology & Oncology
|
January 7, 2017
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
Giovanni Luca Gravina, Andrea Mancini, Francesco Marampon, et al.
International Journal of Molecular Sciences
|
September 9, 2022
The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
Tania Colasanti, Katia Stefanantoni, Cristina Fantini, et al.
Page
of 16